THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

Peter Johnson to Infant

This is a "connection" page, showing publications Peter Johnson has written about Infant.
Connection Strength

1.383
  1. Ketamine infusions as an adjunct for sedation in critically ill children. J Opioid Manag. 2022 Jan-Feb; 18(1):57-68.
    View in: PubMed
    Score: 0.152
  2. Analysis of fentanyl pharmacokinetics, and its sedative effects and tolerance in critically ill children. Pharmacotherapy. 2021 04; 41(4):359-369.
    View in: PubMed
    Score: 0.145
  3. Evaluation of dosing and safety outcomes of low-dose prophylactic warfarin in children after cardiothoracic surgery. Am J Health Syst Pharm. 2020 06 23; 77(13):1018-1025.
    View in: PubMed
    Score: 0.137
  4. Hyponatremia With Intravenous Sulfamethoxazole/Trimethoprim in Children. Ann Pharmacother. 2020 04; 54(4):351-358.
    View in: PubMed
    Score: 0.131
  5. Detectable Concentrations of Inhaled Tobramycin in Critically Ill Children Without Cystic Fibrosis: Should Routine Monitoring Be Recommended? Pediatr Crit Care Med. 2017 Dec; 18(12):e615-e620.
    View in: PubMed
    Score: 0.115
  6. Clonidine for Sedation and Analgesia and Withdrawal in Critically Ill Infants and Children. Pharmacotherapy. 2016 12; 36(12):1290-1299.
    View in: PubMed
    Score: 0.107
  7. Ketamine Continuous Infusions in Critically Ill Infants and Children. Ann Pharmacother. 2016 Mar; 50(3):234-41.
    View in: PubMed
    Score: 0.101
  8. A pilot study assessing the frequency and complexity of methadone tapers for opioid abstinence syndrome in children discharged to home. Res Social Adm Pharm. 2012 Sep-Oct; 8(5):455-63.
    View in: PubMed
    Score: 0.076
  9. Continuous-infusion neuromuscular blocking agents in critically ill neonates and children. Pharmacotherapy. 2011 Jun; 31(6):609-20.
    View in: PubMed
    Score: 0.073
  10. Utility of transdermal fentanyl for prevention of iatrogenic opioid abstinence syndrome in children. J Opioid Manag. 2010 Mar-Apr; 6(2):117-24.
    View in: PubMed
    Score: 0.067
  11. Utilisation of Crotalidae polyvalent immune fab (ovine) for Viperidae envenomations in children. Emerg Med J. 2008 Dec; 25(12):793-8.
    View in: PubMed
    Score: 0.062
  12. Characterization of community-acquired Staphylococcus aureus infections in children. Ann Pharmacother. 2007 Sep; 41(9):1361-7.
    View in: PubMed
    Score: 0.056
  13. 2022 Society of Critical Care Medicine Clinical Practice Guidelines on Prevention and Management of Pain, Agitation, Neuromuscular Blockade, and Delirium in Critically Ill Pediatric Patients With Consideration of the ICU Environment and Early Mobility. Pediatr Crit Care Med. 2022 02 01; 23(2):e74-e110.
    View in: PubMed
    Score: 0.038
  14. Frequency and Severity of Chlorothiazide-Induced Hyponatremia in the Neonatal Intensive Care Unit. Am J Perinatol. 2022 09; 39(12):1354-1361.
    View in: PubMed
    Score: 0.036
  15. Pseudohyperphosphatemia in children treated with liposomal amphotericin B. Am J Health Syst Pharm. 2014 Sep 01; 71(17):1462-8.
    View in: PubMed
    Score: 0.023
  16. Association of fentanyl with neurodevelopmental outcomes in very-low-birth-weight infants. Ann Pharmacother. 2014 Mar; 48(3):335-42.
    View in: PubMed
    Score: 0.022
  17. Acetazolamide in critically ill neonates and children with metabolic alkalosis. Ann Pharmacother. 2013 Sep; 47(9):1130-5.
    View in: PubMed
    Score: 0.021
  18. Bumetanide continuous-infusion dosing in critically ill pediatric patients. Am J Health Syst Pharm. 2012 Sep 01; 69(17):1458, 1460-1.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES